Literature DB >> 1729284

Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts.

D M Milewicz1, R E Pyeritz, E S Crawford, P H Byers.   

Abstract

We studied the synthesis, secretion, and aggregation into the extracellular matrix of fibrillin by dermal fibroblasts from 26 probands with the Marfan syndrome. Cells from seven probands synthesized approximately half the normal amount of fibrillin when compared with intrafamilial or unrelated controls. Cells from an additional seven probands synthesized a normal amount of fibrillin but secreted the protein less efficiently than control cells. Cells from a further eight probands synthesized and secreted normal amounts of fibrillin but the protein was poorly incorporated into extracellular matrix. Cells from the remaining four probands were indistinguishable from control cells in their synthesis and processing of fibrillin. Cells from 18 family members of 10 of the probands were also studied. Cells from affected individuals in the same family had the same biochemical defect and those from unaffected family members were indistinguishable from controls. These results indicate that mutations in the gene that encodes fibrillin are responsible for the Marfan syndrome in the majority of individuals (confirming recent immunohistochemical and genetic linkage studies) and that a variety of mutations can produce the phenotype associated with the syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729284      PMCID: PMC442822          DOI: 10.1172/JCI115589

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta.

Authors:  J Bonadio; K A Holbrook; R E Gelinas; J Jacob; P H Byers
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

Review 2.  The Marfan syndrome: diagnosis and management.

Authors:  R E Pyeritz; V A McKusick
Journal:  N Engl J Med       Date:  1979-04-05       Impact factor: 91.245

3.  Synthesis and degradation of hyaluronic acid in the cultured fibroblasts of Marfan's disease.

Authors:  S I Lamberg; A Dorfman
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

4.  The fine structure of the ciliary zonule and ciliary epithelium. With special regard to the organization and insertion of the zonular fibrils.

Authors:  G Raviola
Journal:  Invest Ophthalmol       Date:  1971-11

5.  Location on chromosome 15 of the gene defect causing Marfan syndrome.

Authors:  K Kainulainen; L Pulkkinen; A Savolainen; I Kaitila; L Peltonen
Journal:  N Engl J Med       Date:  1990-10-04       Impact factor: 91.245

Review 6.  Elastin-associated microfibrils and microfibrillar proteins.

Authors:  E G Cleary; M A Gibson
Journal:  Int Rev Connect Tissue Res       Date:  1983

7.  Structural abnormalities in the dermal collagen and elastic matrix from the skin of patients with inherited connective tissue disorders.

Authors:  K A Holbrook; P H Byers
Journal:  J Invest Dermatol       Date:  1982-07       Impact factor: 8.551

8.  Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndrome.

Authors:  M Godfrey; S Olson; R G Burgio; A Martini; M Valli; G Cetta; H Hori; D W Hollister
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

9.  Immunohistochemical comparison of ocular zonules and the microfibrils of elastic tissue.

Authors:  B W Streeten; P A Licari; A A Marucci; R M Dougherty
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-07       Impact factor: 4.799

10.  Cell-free synthesis of hyaluronic acid in Marfan syndrome.

Authors:  A Appel; A L Horwitz; A Dorfman
Journal:  J Biol Chem       Date:  1979-12-10       Impact factor: 5.157

View more
  53 in total

1.  Profibrillin-1 maturation by human dermal fibroblasts: proteolytic processing and molecular chaperones.

Authors:  Debra D Wallis; Elizabeth A Putnam; Jill S Cretoiu; Sonya G Carmical; Shi-Nian Cao; Gary Thomas; Dianna M Milewicz
Journal:  J Cell Biochem       Date:  2003-10-15       Impact factor: 4.429

2.  2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

Authors:  Harry C Dietz
Journal:  Am J Hum Genet       Date:  2007-10       Impact factor: 11.025

Review 3.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

Review 4.  Marfan syndrome.

Authors:  J R Gray; S J Davies
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

Review 5.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

6.  Of mice and Marfan: genetic linkage analyses of the fibrillin genes, Fbn1 and Fbn2, in the mouse genome.

Authors:  C Goldstein; P Liaw; S A Jimenez; A M Buchberg; L D Siracusa
Journal:  Mamm Genome       Date:  1994-11       Impact factor: 2.957

7.  Fibrillin-1 and -2 contain heparin-binding sites important for matrix deposition and that support cell attachment.

Authors:  Timothy M Ritty; Thomas J Broekelmann; Claudio C Werneck; Robert P Mecham
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

8.  Early fibrillin-1 assembly monitored through a modifiable recombinant cell approach.

Authors:  Dirk Hubmacher; Eric Bergeron; Christine Fagotto-Kaufmann; Lynn Y Sakai; Dieter P Reinhardt
Journal:  Biomacromolecules       Date:  2014-03-07       Impact factor: 6.988

Review 9.  Identification of defects in the fibrillin gene and protein in individuals with the Marfan syndrome and related disorders.

Authors:  D M Milewicz
Journal:  Tex Heart Inst J       Date:  1994

10.  Determination of the molecular basis of Marfan syndrome: a growth industry.

Authors:  Peter H Byers
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.